Irccs Istituto Ortopedico Rizzoli — Bologna, Emilia-Romagna

Public research footprint of Irccs Istituto Ortopedico Rizzoli, compiled from the ClinicalTrials.gov public registry.

120

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Tenosynovial Giant Cell Tumor · Desmoid Tumor · Osteoarthritis, Knee · Giant Cell Tumor of Tendon Sheath

Recently updated registry entries

NCT05999994 — A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children… (Recruiting)
NCT07176689 — Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) (Recruiting)
NCT04950075 — Study of INBRX-109 in Conventional Chondrosarcoma (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Irccs Istituto Ortopedico Rizzoli?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.